Taken together, these data suggest that local enrichment of DDB2 coincides with chromatin condensation at the potential DDB2 binding site of the NEDD4L promoter region, providing a previously unknown new mechanism for the DDB2-mediated NEDD4L transcription inhibition observed in human ovarian cancer cells. Here, DDB2 is linked to ovarian carcinoma.